This inventor holds 1 USPTO granted patent. Top assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.a.. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: The Innovative Contributions of Luca Battistini
Introduction
Luca Battistini is a notable inventor based in Rome, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of autoimmune diseases. His innovative approach has led to the development of a unique compound that shows promise in addressing various health conditions.
Latest Patents
Luca Battistini holds a patent for the use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases. This patent outlines a method for treating subjects affected by autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis. The invention involves administering an effective amount of the compound to the subject. Additionally, the patent describes a method for inhibiting γδ T cells in individuals in need of such treatment.
Career Highlights
Luca Battistini is associated with Sigma-Tau Industrie Farmaceutiche Riunite S.p.a., where he has been instrumental in advancing pharmaceutical research. His work focuses on innovative solutions for complex medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Luca collaborates with esteemed colleagues such as Giovanna Borsellino and Rita De Santis. Their combined expertise contributes to the ongoing research and development efforts within their organization.
Conclusion
Luca Battistini's contributions to the field of pharmaceuticals, particularly through his patent for treating autoimmune diseases, highlight his role as an innovative inventor. His work continues to pave the way for advancements in medical treatments, benefiting many individuals affected by these conditions.